Trust evidence,
not marketing.

Every week, people across the UK buy peptides on the strength of a marketing claim. We think they deserve the evidence first.

PeptideClear looks at the evidence behind peptides, products and the businesses selling them, so you can see what stands up and what doesn't.

The UK reference

PeptideClear Trust Index

live

Showing Testing Transparency — one of three separate measures, not an overall grade

24 retailers currently meet the A− or above threshold for Testing Transparency, out of 151 graded (159 assessed in total)
A+B+CD
159assessed
195tracked
36not yet assessed

Testing Transparency only, not an overall Trust Index grade · last verified 21 August 2026 · free to every seller, no payment for a better result

What this is

PeptideClear works like Which? Trusted Traders or Checkatrade, but for UK research-peptide sellers. We check the evidence across three separate measures — Testing Transparency, Business Transparency and Responsible Practice — rather than asking other customers what they thought. Every UK seller we can find is checked the same way, for free. Nobody pays to be included, and nobody pays for a better result.

If you sell research peptides in the UK

You don't need to apply. We identify UK sellers and assess what's publicly checkable on your own site. If something we find looks significant, we'll usually try to reach you for context. See how the assessment works →

Testing Transparency — one of three separate measures, not an overall Trust Index grade

159 assessed
A+ · 7A · 1A− · 16B+ · 26B · 13B− · 11C · 17D · 60
24at grade A− or above
195reviewed & tracked
36not yet assessed

36 sellers are tracked but not yet assessed at all. Of the 159 that have been assessed, 151 carry a Testing Transparency grade (shown above); the remaining 8 are flagged for further review and not yet graded — not yet assessed is a fact, not a grade.

At a glance 27 compounds mapped 304 studies referenced 21 regulatory updates tracked 24 at grade A− testing transparency

Explore PeptideClear

Research asset

The Evidence Map

Every peptide we cover is placed by how far its evidence actually goes, from animal studies to human randomised trials, and grouped by what people use it for.

Animal only Mixed evidence Human RCTs

Grouped by what people use it for

Recovery & repair Growth hormone Metabolic & GLP-1 Longevity Skin & cosmetic Sexual health Cognitive Immune modulating
27compounds
304studies referenced
Open the full Evidence Map →

What changed

Regulatory hub →
MHRAUK first in Europe to authorise orforglipron for weight management and type 2 diabetes10 Aug
MHRANo summer shortcut for safe weight loss24 Jul
MHRAMHRA grants conditional approval for semaglutide (Wegovy) to treat MASH in adults with moderate to advanced liver fibrosis3 Jul
MHRAMHRA, ASA and GPhC issue a joint warning on promoting newly licensed prescription-only and unlicensed weight-management medicines18 Jun

Evidence, rated plainly

One scale, on every compound. Filled pips show how far the evidence goes: animal work, mixed human data, or human randomised trials.

BPC-157
ANIMAL ONLY
MOTS-c
MIXED EVIDENCE
GHK-Cu
MIXED EVIDENCE
TB-500
ANIMAL ONLY
CJC-1295
MIXED EVIDENCE
Ipamorelin
ANIMAL ONLY
See the full evidence rating for every compound →

Become a smarter buyer

Learn to verify quality yourself

All guides →

Editor's desk

Latest research

All posts →

What PeptideClear does

Independent information and assessment. We don't sell research peptides, dispense medicines or prescribe treatment — we assess UK retailers on observable, published signals across three separate measures, and link out.

We summarise UK peptide categories in plain English. No payment changes an assessment result, and we don't recommend a specific medication or supplement to a specific person. The decision is yours: for prescription medicine the prescriber decides; for research peptides the retailer's “research use only” framing applies.

Before you buy anywhere

How to check a weight-loss medicine seller is legitimate

Every GLP-1 weight-management medicine licensed in the UK is prescription-only, so a site that sells you one without a prescriber is supplying illegally. Check the seller on the GPhC register, check the prescriber on the GMC register, and treat a price well under the registered-pharmacy range as a warning rather than a find. The MHRA reported seizing more than 5,000 illegally traded GLP-1 products in 2025 alone.

Our live data trackers

PeptideClear maintains these as refreshable datasets rather than one-off articles. Each carries its own source, methodology and last-updated date.

UK GLP-1 prescribing tracker

Monthly NHS England primary-care prescribing volumes for GLP-1 medications, rebuilt as each new month publishes.

Source: NHSBSA English Prescribing Dataset

UK peptide clinical-trials tracker

Registered interventional trials for every research peptide we track, by phase and recruitment status.

Source: ClinicalTrials.gov and ISRCTN

MHRA enforcement & safety tracker

Every MHRA safety alert, enforcement action and drug safety update relevant to weight-loss medicines and peptides.

Source: gov.uk / MHRA

UK peptide regulation: monthly overview

Combines the MHRA feed with a monthly web-search pass for ASA rulings, Trading Standards action and named-retailer enforcement.

Source: gov.uk / MHRA / ASA / Trading Standards

PeptideClear Trust Index

159 UK sellers scored on six observable certificate-of-analysis signals, free and independently.

Source: PeptideClear methodology

Data API and MCP server

Read-only, no-auth REST API and MCP server over the full scored dataset. CC BY 4.0.

Source: PeptideClear, live data

Related on PeptideClear

UK longevity clinics pillar → Terms explained → Side-by-side comparisons → UK regulatory hub → Best UK longevity clinics → UK clinics directory →